Exploring the trimethylamine pathway in advanced chronic liver disease
Abstract The trimethylamine (TMA)-trimethylamine-N-oxide (TMAO) pathway, involving gut microbiota-derived metabolites, may play a role in advanced chronic liver disease (ACLD). This study assessed TMA and TMAO levels in ACLD patients and their associations with liver-related outcomes. Plasma samples...
Saved in:
| Main Authors: | Jil T. Bürki, Jonas Schropp, Peter Neyer, Christian Steuer, Jaume Bosch, Annalisa Berzigotti, Susana G. Rodrigues |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Gut and Liver |
| Online Access: | https://doi.org/10.1038/s44355-025-00029-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research advances of trimethylamine N-oxide and chronic kidney diseases
by: Liu Mei-jun, et al.
Published: (2021-01-01) -
Exploring the trimethylamine-degrading genes in the human gut microbiome
by: Yi-Ran Chen, et al.
Published: (2025-06-01) -
Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01) -
The Toxicity of Trimethylamine for Necrophorus Orbicollis (Say)
by: Cyril E. Abbott
Published: (1936-01-01) -
Structural basis of a microbial trimethylamine transporter
by: Chao Gao, et al.
Published: (2025-01-01)